Publications
83
Citations
3,513
Est. group size
~1
Recurring co-author estimate
Active years
30
Publishing since 1996
Bart Gerritse's work centers on cardiac electronic devices used to treat heart failure and abnormal heart rhythms, including pacemakers, defibrillators, and cardiac resynchronization therapy (a treatment that helps the heart's chambers beat in a more coordinated way). Much of the research evaluates how well these devices work in real-world and clinical trial settings, including remote monitoring systems that track patients' heart health from home and algorithms that help detect dangerous arrhythmias. Some recent work also touches on breathing-related measurements in patients with chronic obstructive pulmonary disease (COPD).
Publication output has fluctuated over the last decade, dipping in the early 2020s before rising again to a recent peak in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Adaptive versus conventional cardiac resynchronization therapy in asian heart failure patients with moderately wide QRS: primary results from the Mid-Q Response randomized trial
EP Europace · 2025
- Respiratory EMG and dyspnea during exercise in COPD patients
2025
- Dyspnea and respiratory EMG in patients with COPD: results of the COPD monitoring study
Journal of Applied Physiology · 2025
- Association of a Device-Based Remote Management Heart Failure Pathway with Outcomes: TriageHF Plus Real-World Evaluation
ESC Heart Failure · 2024
- CI-482892-001 ACCURACY OF AN ARTIFICIAL INTELLIGENCE ALGORITHM IN THE DETECTION AND IDENTIFICATION OF VT/VF IN PATIENTS WITH INSERTABLE CARDIAC MONITORS
Heart Rhythm · 2024
- Clinical outcomes of the AdaptResponse trial – Authors' reply
The Lancet · 2024
- Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
The Lancet · 2023
- Association of a Device-Based Remote Management Heart Failure Care Pathway with Hospitalisation and Patient Outcomes: Triagehf Plus Real-World Clinical Evaluation
SSRN Electronic Journal · 2023
- Performance evaluation of implantable cardioverter-defibrillators with SmartShock technology in patients with inherited arrhythmogenic diseases
International Journal of Cardiology · 2022
- Identifying high risk patients post myocardial infarction with reduced left ventricular function using loop recorders INSPIRE-ELR clinical study
Indian Heart Journal · 2022
- Use of a device-based remote management heart failure care pathway is associated with reduced hospitalization and improved patient outcomes: TriageHF Plus real-world evaluation
European Heart Journal · 2022
- Use of a device-based remote management heart failure care pathway is associated with reduced hospitalization and improved patient outcomes: TriageHF Plus real-world evaluation
European Heart Journal - Digital Health · 2022
- Design of <scp>Mid‐Q</scp> Response: A prospective, randomized trial of adaptive cardiac resynchronization therapy in Asian patients
Journal of Arrhythmia · 2022
- Abstract 13787: Use of a Novel Cardiac Implantable Electronic Device Digital Care Pathway (TriageHF-Plus) is Associated With a Reduction in All-Cause Unplanned Hospitalizations
Circulation · 2021
- Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices
Journal of Cardiovascular Electrophysiology · 2020
- European Heart Journal×6
- Heart Rhythm×5
- EP Europace×4
- ESC Heart Failure×3
- Pacing and Clinical Electrophysiology×3
- Michael Mirro
Medicine · Indiana University
- Raul Weiss
Medicine · The Ohio State University
- Ziqing Yu
Medicine · Purdue University West Lafayette
- Cindy M. Baker
Medicine · The Ohio State University
- Rami Kahwash
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile